{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T07:07:32Z","timestamp":1771744052115,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["COV20\/00470"],"award-info":[{"award-number":["COV20\/00470"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s10787-024-01568-y","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T09:01:53Z","timestamp":1727082113000},"page":"3697-3705","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The role of traditional NSAIDs and selective COX-2 inhibitors on COVID-19 outcomes: a real-world data study"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3711-3792","authenticated-orcid":false,"given":"Narmeen","family":"Mallah","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6466-6213","authenticated-orcid":false,"given":"Irene","family":"Visos-Varela","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0739-2241","authenticated-orcid":false,"given":"Bahi","family":"Takkouche","sequence":"additional","affiliation":[]},{"given":"Rosendo","family":"Bugar\u00edn-Gonz\u00e1lez","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3655-100X","authenticated-orcid":false,"given":"Mar\u00eda","family":"Pi\u00f1eiro-Lamas","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0500-4049","authenticated-orcid":false,"given":"Teresa","family":"Herdeiro","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0648-7716","authenticated-orcid":false,"given":"Maruxa","family":"Zapata-Cachafeiro","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3350-1237","authenticated-orcid":false,"given":"Almudena","family":"Rodr\u00edguez-Fern\u00e1ndez","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4349-4947","authenticated-orcid":false,"given":"Angel","family":"Salgado-Barreira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5766-8672","authenticated-orcid":false,"given":"Adolfo","family":"Figueiras","sequence":"additional","affiliation":[]},{"name":"COVIDrug Group","sequence":"additional","affiliation":[]},{"given":"Eduardo","family":"Carracedo-Mart\u00ednez","sequence":"additional","affiliation":[]},{"given":"Rosa M.","family":"Garc\u00eda-\u00c1lvarez","sequence":"additional","affiliation":[]},{"given":"Francisco J.","family":"Gonz\u00e1lez-Barcala","sequence":"additional","affiliation":[]},{"given":"Teresa M","family":"Herdeiro","sequence":"additional","affiliation":[]},{"given":"Martina","family":"Lema-Oreiro","sequence":"additional","affiliation":[]},{"given":"Samuel","family":"Pintos-Rodr\u00edguez","sequence":"additional","affiliation":[]},{"given":"Maria","family":"Pi\u00f1eiro-Lamas","sequence":"additional","affiliation":[]},{"given":"Manuel","family":"Portela-Romero","sequence":"additional","affiliation":[]},{"given":"Angela","family":"Prieto-Campo","sequence":"additional","affiliation":[]},{"given":"Almudena","family":"Rodriguez-Fern\u00e1ndez","sequence":"additional","affiliation":[]},{"given":"Marc","family":"Saez","sequence":"additional","affiliation":[]},{"given":"Margarita","family":"Taracido-Trunk","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"1568_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ijid.2020.09.1466","volume":"101","author":"S Baghaki","year":"2020","unstructured":"Baghaki S, Yalcin CE, Baghaki HS et al (2020) COX2 inhibition in the treatment of COVID-19: Review of literature to propose repositioning of celecoxib for randomized controlled studies. Int J Infect Dis 101:29\u201332. https:\/\/doi.org\/10.1016\/j.ijid.2020.09.1466","journal-title":"Int J Infect Dis"},{"key":"1568_CR2","volume-title":"Applied mixed models in medicine","author":"H Brown","year":"2015","unstructured":"Brown H, Prescott R (2015) Applied mixed models in medicine. Wiley"},{"key":"1568_CR3","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.3390\/jcm9082586","volume":"9","author":"E Bruce","year":"2020","unstructured":"Bruce E, Barlow-Pay F, Short R et al (2020) Prior routine use of non-steroidal anti-inflammatory drugs (NSAIDs) and important outcomes in hospitalised patients with COVID-19. J Clin Med 9:2586. https:\/\/doi.org\/10.3390\/jcm9082586","journal-title":"J Clin Med"},{"key":"1568_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0267462","volume":"17","author":"HM Campbell","year":"2022","unstructured":"Campbell HM, Murata AE, Conner TA, Fotieo G (2022a) Chronic use of non-steroidal anti-inflammatory drugs (NSAIDs) or acetaminophen and relationship with mortality among United States Veterans after testing positive for COVID-19. PLoS ONE 17:e0267462. https:\/\/doi.org\/10.1371\/journal.pone.0267462","journal-title":"PLoS ONE"},{"key":"1568_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jpeds.2022.02.048","volume":"245","author":"JI Campbell","year":"2022","unstructured":"Campbell JI, Dubois MM, Savage TJ et al (2022b) Comorbidities Associated with Hospitalization and Progression Among Adolescents with Symptomatic Coronavirus Disease 2019. J Pediatr 245:102-110.e2. https:\/\/doi.org\/10.1016\/j.jpeds.2022.02.048","journal-title":"J Pediatr"},{"key":"1568_CR6","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1213\/ANE.0000000000005292","volume":"132","author":"JH Chow","year":"2021","unstructured":"Chow JH, Khanna AK, Kethireddy S et al (2021) Aspirin use is associated with decreased mechanical ventilation, intensive care unit admission, and in-hospital mortality in hospitalized patients With Coronavirus Disease 2019. Anesth Analg 132:930\u2013941. https:\/\/doi.org\/10.1213\/ANE.0000000000005292","journal-title":"Anesth Analg"},{"key":"1568_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.785785","volume":"9","author":"E Consolaro","year":"2022","unstructured":"Consolaro E, Suter F, Rubis N et al (2022) A home-treatment algorithm based on anti-inflammatory drugs to prevent hospitalization of patients with early COVID-19: a matched-cohort study (COVER 2). Front Med 9:785785. https:\/\/doi.org\/10.3389\/fmed.2022.785785","journal-title":"Front Med"},{"key":"1568_CR8","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/S0140-6736(20)31030-8","volume":"395","author":"FJ de Abajo","year":"2020","unstructured":"de Abajo FJ, Rodr\u00edguez-Mart\u00edn S, Lerma V et al (2020) Use of renin\u2013angiotensin\u2013aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study. The Lancet 395:1705\u20131714. https:\/\/doi.org\/10.1016\/S0140-6736(20)31030-8","journal-title":"The Lancet"},{"key":"1568_CR9","doi-asserted-by":"publisher","first-page":"e01583","DOI":"10.1128\/JVI.01583-20","volume":"95","author":"F D\u00edez-Fuertes","year":"2021","unstructured":"D\u00edez-Fuertes F, Iglesias-Caballero M, Garc\u00eda-P\u00e9rez J et al (2021) A founder effect led early SARS-CoV-2 transmission in Spain. J Virol 95:e01583-e1620. https:\/\/doi.org\/10.1128\/JVI.01583-20","journal-title":"J Virol"},{"key":"1568_CR10","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1093\/ndt\/gfp384","volume":"24","author":"P Fabbrini","year":"2009","unstructured":"Fabbrini P, Schilte MN, Zareie M et al (2009) Celecoxib treatment reduces peritoneal fibrosis and angiogenesis and prevents ultrafiltration failure in experimental peritoneal dialysis. Nephrol Dial Transplant 24:3669\u20133676. https:\/\/doi.org\/10.1093\/ndt\/gfp384","journal-title":"Nephrol Dial Transplant"},{"key":"1568_CR11","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1007\/s40121-021-00525-4","volume":"10","author":"M Falcone","year":"2021","unstructured":"Falcone M, Tiseo G, Valoriani B et al (2021) Efficacy of bamlanivimab\/etesevimab and casirivimab\/imdevimab in preventing progression to severe COVID-19 and role of variants of concern. Infect Dis Ther 10:2479\u20132488. https:\/\/doi.org\/10.1007\/s40121-021-00525-4","journal-title":"Infect Dis Ther"},{"key":"1568_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30116-8","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M (2020) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 8:e21. https:\/\/doi.org\/10.1016\/S2213-2600(20)30116-8","journal-title":"Lancet Respir Med"},{"key":"1568_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2060","volume":"374","author":"L Fenton","year":"2021","unstructured":"Fenton L, Gribben C, Caldwell D et al (2021) Risk of hospital admission with covid-19 among teachers compared with healthcare workers and other adults of working age in Scotland, March 2020 to July 2021: population based case\u2013control study. BMJ 374:n2060. https:\/\/doi.org\/10.1136\/bmj.n2060","journal-title":"BMJ"},{"key":"1568_CR14","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1007\/s10787-024-01475-2","volume":"32","author":"RM Garc\u00eda-\u00c1lvarez","year":"2024","unstructured":"Garc\u00eda-\u00c1lvarez RM, Zapata-Cachafeiro M, Visos-Varela I et al (2024) Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient. Inflammopharmacology 32:1805\u20131815. https:\/\/doi.org\/10.1007\/s10787-024-01475-2","journal-title":"Inflammopharmacology"},{"key":"1568_CR15","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s10787-022-01029-4","volume":"30","author":"H Ghaznavi","year":"2022","unstructured":"Ghaznavi H, Mohammadghasemipour Z, Shirvaliloo M et al (2022) Short-term celecoxib (celebrex) adjuvant therapy: a clinical trial study on COVID-19 patients. Inflammopharmacology 30:1645\u20131657. https:\/\/doi.org\/10.1007\/s10787-022-01029-4","journal-title":"Inflammopharmacology"},{"key":"1568_CR16","doi-asserted-by":"publisher","first-page":"eabe9403","DOI":"10.1126\/science.abe9403","volume":"370","author":"DE Gordon","year":"2020","unstructured":"Gordon DE, Hiatt J, Bouhaddou M et al (2020) Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science 370:eabe9403. https:\/\/doi.org\/10.1126\/science.abe9403","journal-title":"Science"},{"key":"1568_CR17","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1001\/jama.2022.2832","volume":"327","author":"A Gupta","year":"2022","unstructured":"Gupta A, Gonzalez-Rojas Y, Juarez E et al (2022) Effect of sotrovimab on hospitalization or death among high-risk patients with mild to moderate COVID-19: a randomized clinical trial. JAMA 327:1236\u20131246. https:\/\/doi.org\/10.1001\/jama.2022.2832","journal-title":"JAMA"},{"key":"1568_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.561674","author":"W Hong","year":"2020","unstructured":"Hong W, Chen Y, You K et al (2020) Celebrex adjuvant therapy on coronavirus disease 2019: an experimental study. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2020.561674","journal-title":"Front Pharmacol"},{"key":"1568_CR19","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1186\/1471-2458-13-1030","volume":"13","author":"CA Huber","year":"2013","unstructured":"Huber CA, Szucs TD, Rapold R, Reich O (2013) Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications. BMC Public Health 13:1030. https:\/\/doi.org\/10.1186\/1471-2458-13-1030","journal-title":"BMC Public Health"},{"key":"1568_CR20","doi-asserted-by":"publisher","first-page":"e4179","DOI":"10.1093\/cid\/ciaa1056","volume":"73","author":"HE Jeong","year":"2021","unstructured":"Jeong HE, Lee H, Shin HJ et al (2021) Association between nonsteroidal antiinflammatory drug use and adverse clinical outcomes among adults hospitalized with coronavirus 2019 in South Korea: a nationwide study. Clin Infect Dis off Publ Infect Dis Soc Am 73:e4179\u2013e4188. https:\/\/doi.org\/10.1093\/cid\/ciaa1056","journal-title":"Clin Infect Dis off Publ Infect Dis Soc Am"},{"key":"1568_CR21","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s10787-021-00810-1","volume":"29","author":"CS Kow","year":"2021","unstructured":"Kow CS, Hasan SS (2021) The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis. Inflammopharmacology 29:641\u2013644. https:\/\/doi.org\/10.1007\/s10787-021-00810-1","journal-title":"Inflammopharmacology"},{"key":"1568_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s42977-023-00159-2","author":"\u00c1 Kun","year":"2023","unstructured":"Kun \u00c1, Hubai AG, Kr\u00e1l A et al (2023) Do pathogens always evolve to be less virulent? The virulence\u2013transmission trade-off in light of the COVID-19 pandemic. Biol Futura. https:\/\/doi.org\/10.1007\/s42977-023-00159-2","journal-title":"Biol Futura"},{"key":"1568_CR23","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s10787-023-01309-7","volume":"31","author":"W Laughey","year":"2023","unstructured":"Laughey W, Lodhi I, Pennick G et al (2023) Ibuprofen, other NSAIDs and COVID-19: a narrative review. Inflammopharmacology 31:2147\u20132159. https:\/\/doi.org\/10.1007\/s10787-023-01309-7","journal-title":"Inflammopharmacology"},{"key":"1568_CR24","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41573-023-00672-y","volume":"22","author":"G Li","year":"2023","unstructured":"Li G, Hilgenfeld R, Whitley R, De Clercq E (2023) Therapeutic strategies for COVID-19: progress and lessons learned. Nat Rev Drug Discov 22:449\u2013475. https:\/\/doi.org\/10.1038\/s41573-023-00672-y","journal-title":"Nat Rev Drug Discov"},{"key":"1568_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.therap.2020.05.003","volume":"75","author":"J Micallef","year":"2020","unstructured":"Micallef J, Soeiro T, Jonville-B\u00e9ra A-P (2020) Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection. Therapie 75:355\u2013362. https:\/\/doi.org\/10.1016\/j.therap.2020.05.003","journal-title":"Therapie"},{"key":"1568_CR26","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s40264-021-01089-5","volume":"44","author":"N Moore","year":"2021","unstructured":"Moore N, Bosco-Levy P, Thurin N et al (2021) NSAIDs and COVID-19: a systematic review and meta-analysis. Drug Saf 44:929\u2013938. https:\/\/doi.org\/10.1007\/s40264-021-01089-5","journal-title":"Drug Saf"},{"key":"1568_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1159","volume":"9","author":"SWX Ong","year":"2020","unstructured":"Ong SWX, Tan WYT, Chan Y et al (2020) Safety and potential efficacy of cyclooxygenase-2 inhibitors in coronavirus disease 2019. Clin Transl Immunol 9:e1159. https:\/\/doi.org\/10.1002\/cti2.1159","journal-title":"Clin Transl Immunol"},{"key":"1568_CR28","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1016\/S1473-3099(22)00433-9","volume":"23","author":"N Perico","year":"2023","unstructured":"Perico N, Cortinovis M, Suter F, Remuzzi G (2023) Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents. Lancet Infect Dis 23:e22\u2013e33. https:\/\/doi.org\/10.1016\/S1473-3099(22)00433-9","journal-title":"Lancet Infect Dis"},{"key":"1568_CR29","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1136\/jnnp-2020-324927","volume":"92","author":"RJ Perry","year":"2021","unstructured":"Perry RJ, Smith CJ, Roffe C et al (2021) Characteristics and outcomes of COVID-19 associated stroke: a UK multicentre case\u2013control study. J Neurol Neurosurg Psychiatry 92:242\u2013248. https:\/\/doi.org\/10.1136\/jnnp-2020-324927","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1568_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-0318-1","volume-title":"Mixed-effects models in S and S-PLUS","author":"J Pinheiro","year":"2000","unstructured":"Pinheiro J, Bates D (2000) Mixed-effects models in S and S-PLUS. Springer Science & Business Media, Berlin"},{"key":"1568_CR31","doi-asserted-by":"publisher","DOI":"10.2202\/1557-4679.1127","author":"S Rose","year":"2009","unstructured":"Rose S, van der Laan MJ (2009) Why match? Investigating matched case-control study designs with causal effect estimation. Int J Biostat. https:\/\/doi.org\/10.2202\/1557-4679.1127","journal-title":"Int J Biostat"},{"key":"1568_CR32","doi-asserted-by":"crossref","unstructured":"Rothman KJ, Greenland S, Lash TL (2008) Case\u2013control studies. In: Melnick EL, Everitt BS (eds) Encyclopedia of quantitative risk analysis and assessment. Wiley, Hoboken","DOI":"10.1002\/9780470061596.risk0599"},{"key":"1568_CR33","doi-asserted-by":"publisher","first-page":"SI5","DOI":"10.1093\/rheumatology\/keab348","volume":"60","author":"S Spila Alegiani","year":"2021","unstructured":"Spila Alegiani S, Crisafulli S, Giorgi Rossi P et al (2021) Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy. Rheumatol Oxf Engl 60:SI5\u2013SI36. https:\/\/doi.org\/10.1093\/rheumatology\/keab348","journal-title":"Rheumatol Oxf Engl"},{"key":"1568_CR34","volume-title":"Generalized linear mixed models: modern concepts, methods and applications","author":"WW Stroup","year":"2012","unstructured":"Stroup WW (2012) Generalized linear mixed models: modern concepts, methods and applications. CRC Press"},{"key":"1568_CR35","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2165\/11592140-000000000-00000","volume":"34","author":"H Th\u00e9ophile","year":"2011","unstructured":"Th\u00e9ophile H, Laporte J-R, Moore N et al (2011) The case-population study design: an analysis of its application in pharmacovigilance. Drug Saf 34:861\u2013868. https:\/\/doi.org\/10.2165\/11592140-000000000-00000","journal-title":"Drug Saf"},{"key":"1568_CR36","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1194\/jlr.RA119000141","volume":"60","author":"H-C Tseng","year":"2019","unstructured":"Tseng H-C, Lin C-C, Hsiao L-D, Yang C-M (2019) Lysophosphatidylcholine-induced mitochondrial fission contributes to collagen production in human cardiac fibroblasts[S]. J Lipid Res 60:1573\u20131589. https:\/\/doi.org\/10.1194\/jlr.RA119000141","journal-title":"J Lipid Res"},{"key":"1568_CR37","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/bcp.14514","volume":"87","author":"R Vaja","year":"2021","unstructured":"Vaja R, Chan JSK, Ferreira P et al (2021) The COVID-19 ibuprofen controversy: a systematic review of NSAIDs in adult acute lower respiratory tract infections. Br J Clin Pharmacol 87:776\u2013784. https:\/\/doi.org\/10.1111\/bcp.14514","journal-title":"Br J Clin Pharmacol"},{"key":"1568_CR38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.euroneuro.2023.03.011","volume":"71","author":"I Visos-Varela","year":"2023","unstructured":"Visos-Varela I, Zapata-Cachafeiro M, Pi\u00f1eiro-Lamas M et al (2023a) Repurposing selective serotonin reuptake inhibitors for severity of COVID-19: a population-based study. Eur Neuropsychopharmacol 71:96\u2013108. https:\/\/doi.org\/10.1016\/j.euroneuro.2023.03.011","journal-title":"Eur Neuropsychopharmacol"},{"key":"1568_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28971","volume":"95","author":"I Visos-Varela","year":"2023","unstructured":"Visos-Varela I, Zapata-Cachafeiro M, Pintos-Rodr\u00edguez S et al (2023b) Outpatient atorvastatin use and severe COVID-19 outcomes: A population-based study. J Med Virol 95:e28971. https:\/\/doi.org\/10.1002\/jmv.28971","journal-title":"J Med Virol"},{"key":"1568_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13557","volume":"74","author":"M Yousefifard","year":"2020","unstructured":"Yousefifard M, Zali A, Zarghi A et al (2020) Non-steroidal anti-inflammatory drugs in management of COVID-19; A systematic review on current evidence. Int J Clin Pract 74:e13557. https:\/\/doi.org\/10.1111\/ijcp.13557","journal-title":"Int J Clin Pract"},{"key":"1568_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15512.10.1111\/bcp.15512","author":"H Zhao","year":"2022","unstructured":"Zhao H, Huang S, Huang S et al (2022) Prevalence of NSAID use among people with COVID-19 and the association with COVID-19-related outcomes: Systematic review and meta-analysis. Br J Clin Pharmacol. https:\/\/doi.org\/10.1111\/bcp.15512.10.1111\/bcp.15512","journal-title":"Br J Clin Pharmacol"},{"key":"1568_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101373","volume":"46","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Zhao S, Gan L et al (2022) Use of non-steroidal anti-inflammatory drugs and adverse outcomes during the COVID-19 pandemic: a systematic review and meta-analysis. EClinicalMedicine 46:101373. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101373","journal-title":"EClinicalMedicine"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01568-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-024-01568-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01568-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T16:08:54Z","timestamp":1731168534000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-024-01568-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1568"],"URL":"https:\/\/doi.org\/10.1007\/s10787-024-01568-y","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]},"assertion":[{"value":"5 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained from the Galician Clinical Research Ethics Committee (Comit\u00e9 de \u00c9tica de Investigaci\u00f3n de Galicia, reference 2020\/349), certified by the Spanish Agency of Medicines and Medical Devices (Agencia Espa\u00f1ola del Medicamento y Productos Sanitarios), and was performed in line with the principles of the Declaration of Helsinki and the prevailing legislation governing biomedical research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}